SCHEMBL26075867

SCHEMBL26075867

CCCCOc1ccc(-c2ccc(-c3cc(C)c4cc(P)ccc4n3)cc2F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ DHODH Q02127 2/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ RARA P10276 1/20 0.38
▸ RARB P10826 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ XDH P47989 1/20 0.36
▸ HMOX1 P09601 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075877 0.98 PLA2G2A (0.41) PLA2G2AKDM4ENPC1ALDH1A1MAPT
SCHEMBL26075878 0.97 PLA2G2A (0.41) PLA2G2AKDM4ENPC1ALDH1A1MAPT
SCHEMBL26075868 0.97 PLA2G2A (0.41) PLA2G2AKDM4ENPC1ALDH1A1MAPT
SCHEMBL26075880 0.97 PLA2G2A (0.41) PLA2G2AKDM4ENPC1ALDH1A1MAPT
SCHEMBL26075866 0.96 DHODH (0.43) PLA2G2ADHODHPDE10A
SCHEMBL26075902 0.92 NCF1 (0.37) PLA2G2AKDM4ENPC1ALDH1A1HPGD
SCHEMBL26075885 0.92 HMOX1 (0.41) KDM4ENPC1ALDH1A1MAPTHPGD
SCHEMBL26075897 0.91 SQOR (0.37) PLA2G2AALDH1A1DHODHPDE10A
SCHEMBL26075237 0.90 PLA2G2A (0.44) PLA2G2AKDM4ENPC1ALDH1A1MAPT
SCHEMBL26075882 0.89 MAPT (0.39) PLA2G2AMAPTDHODHPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD PLA2G2A 1679/4885KDM4E 1396/4885NPC1 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback